Diabetes Affects the A1 Adenosine Receptor-Dependent Action of Diadenosine Tetraphosphate (Ap4A) on Cortical and Medullary Renal Blood Flow
Diabetes through adenosine A1 receptor (A<sub>1</sub>R) and P2 receptors (P2Rs) may lead to disturbances in renal microvasculature. We investigated the renal microvascular response to Ap<sub>4</sub>A, an agonist of P2Rs, in streptozotocin-induced diabetic rats. Using laser Doppler flowmetry, renal blood perfusion (RBP) was measured during infusion of Ap<sub>4</sub>A alone or in the presence of A<sub>1</sub>R antagonist, either DPCPX (8-cyclopentyl-1,3-dipropylxanthine) or 8-cyclopentyltheophylline (CPT). Ap<sub>4</sub>A induced a biphasic response in RBP: a phase of rapid decrease was followed by a rapid increase, which was transient in diabetic rats but extended for 30 min in nondiabetic rats. Phase of decreased RBP was not affected by DPCPX or CPT in either group. Early and extended increases in RBP were prevented by DPCPX and CPT in nondiabetic rats, while in diabetic rats, the early increase in RBP was not affected by these antagonists. A<sub>1</sub>R mRNA and protein levels were increased in isolated glomeruli of diabetic rats, but no changes were detected in P2Y<sub>1</sub>R and P2Y<sub>2</sub>R mRNA. Presence of unblocked A<sub>1</sub>R is a prerequisite for the P2R-mediated relaxing effect of Ap<sub>4</sub>A in nondiabetic conditions, but influence of A<sub>1</sub>R on P2R-mediated renal vasorelaxation is abolished under diabetic conditions.